Trial of Temozolomide, Bevacizumab Plus Bortezomib for Recurrent Glioblastoma Multiforme
NCT01435395
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Glioblastoma Multiforme
Interventions
DRUG:
Temozolomide, bevacizumab and bortezomib
Sponsor
Emory University
Collaborators
[object Object]
[object Object]
[object Object]